Ana M. Catafau

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.

Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.

Journal: NeuroImage. Clinical
Published: February 20, 2017

Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PET.

Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PET.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 17, 2016

Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease.

Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease.

Journal: Neurodegenerative disease management
Published: November 05, 2016

Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation.

Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation.

Journal: Current Alzheimer research
Published: February 14, 2016

Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios?

Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios?

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 05, 2016

Tau: From research to clinical development.

Tau: From research to clinical development.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 15, 2016

Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study.

Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 09, 2015

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl.

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 19, 2015

Age dependence of brain β-amyloid deposition in Down syndrome: An [18F]florbetaben PET study.

Age dependence of brain β-amyloid deposition in Down syndrome: An [18F]florbetaben PET study.

Journal: Neurology
Published: January 09, 2015

Amyloid PET imaging: applications beyond Alzheimer's disease.

Amyloid PET imaging: applications beyond Alzheimer's disease.

Journal: Clinical and translational imaging
Published: November 20, 2014

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 02, 2014

Molecular imaging insights into neurodegeneration: focus on α-synuclein radiotracers.

Molecular imaging insights into neurodegeneration: focus on α-synuclein radiotracers.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 06, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026